hotspot -WSS

hotspot

author：comprehensive 2025-09-03 18:43:15 - browse：6768

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Lung cancer screening guidelines updated for cigarette smokers

leisure time

WSS

Key Senate panel to consider PBM, drug pricing reform package

What is microchimerism and how does it affect maternal health?

European regulators recommend Amylyx's ALS drug be rejected

Explaining an after

Akero's treatment for NASH falls short in cirrhosis study

All of Us, NIH's precision medicine initiative, gets a big boost

focus

hotspot

entertainment

Medicare details structure of new drug price negotiation program

Live blog: Hearing on CRISPR

ChatGPT in medicine: STAT answers readers' burning questions

A revolution in caring for preterm infants

How to save PrEP access — and even expand it

Gene therapy’s promise and the high cost of hope

Guidelines to prevent youth baseball injuries need more muscle

Kidney transplant patients stopped immunosuppressants in trial

Apple is now the first public company to be valued at $3 trillion

Humana CEO Bruce Broussard to step down in 2024

focus

Peter Marks talks Operation Warp Speed for Rare Diseases

How doctors and nurses shape Google's AI

STAT Readout: Today's biotech news includes Sana and Amylyx

Kidney transplant patients stopped immunosuppressants in trial

Bernie Sanders bashes nonprofit hospitals over their tax breaks

How to convince healthy people to buy insurance

explore

focus

leisure time

entertainment